Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53,156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surface modification of hydroxyapatite for hydrogen generation.
Jaworski JW, Kim D, Jung K, Kim S, Jung JH, Jeong JO, Jeon HS, Min BK, Kwon KY. Jaworski JW, et al. Among authors: kim d, kim s. J Colloid Interface Sci. 2011 Jun 15;358(2):598-603. doi: 10.1016/j.jcis.2011.03.068. Epub 2011 Apr 9. J Colloid Interface Sci. 2011. PMID: 21481410
Prevalence of specific antibodies to Chlamydia pneumoniae in Korea.
Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR. Choi TY, et al. Among authors: kim sk, kim da. J Clin Microbiol. 1998 Nov;36(11):3426-8. doi: 10.1128/JCM.36.11.3426-3428.1998. J Clin Microbiol. 1998. PMID: 9774614 Free PMC article.
RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator trial evaluating three interventions for cognitive dysfunction in post-acute sequelae of SARS-CoV-2 infection (PASC).
Knopman DS, Laskowitz DT, Koltai DC, Charvet LE, Becker JH, Federman AD, Wisnivesky J, Mahncke H, Van Vleet TM, Bateman L, Kim DY, O'Steen A, James M, Silverstein A, Lokhnygina Y, Rich J, Feger BJ, Zimmerman KO. Knopman DS, et al. Among authors: kim dy. Trials. 2024 May 17;25(1):326. doi: 10.1186/s13063-024-08156-z. Trials. 2024. PMID: 38755688
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results.
Cortes JE, Sasaki K, Kim DW, Hughes TP, Etienne G, Mauro MJ, Hochhaus A, Lang F, Heinrich MC, Breccia M, Deininger M, Goh YT, Janssen JJWM, Talpaz M, de Soria VGG, le Coutre P, DeAngelo DJ, Damon A, Cacciatore S, Polydoros F, Agrawal N, Rea D. Cortes JE, et al. Among authors: kim dw. Leukemia. 2024 May 16. doi: 10.1038/s41375-024-02278-8. Online ahead of print. Leukemia. 2024. PMID: 38755421
53,156 results
You have reached the last available page of results. Please see the User Guide for more information.